Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial

NCT04835506 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Ulcerative Colitis
Inflammatory Bowel Diseases

Interventions

DRUG: Infliximab

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]